Metraipolis › archive › dc_bee2ee2e7aca

Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis — Europe PMC PMID:41892192

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41892192
DOI
10.3390/curroncol33030164
License (as archived)
solo-consultazione
Archived
2026-11-04T10:26:36.210Z
SHA-256 of the archived text
38a31a3b6f3d6716d51526f81c479702082b707f010d36d6de4664d0af738347
Stable URL of this page
https://metraipolis.com/documento/dc_bee2ee2e7aca

How to cite

Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis — Europe PMC PMID:41892192 — Europe PMC (en), https://europepmc.org/article/MED/41892192 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bee2ee2e7aca (Metraipolis archive dc_bee2ee2e7aca, sha256 38a31a3b6f3d6716d51526f81c479702082b707f010d36d6de4664d0af738347)
BibTeX
@misc{dcbee2ee2e7aca,
  title = {Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis — Europe PMC PMID:41892192},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41892192},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bee2ee2e7aca; sha256 38a31a3b6f3d6716d51526f81c479702082b707f010d36d6de4664d0af738347},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892192. Agents can read the archived copy with the MCP tool read_document.